ORIGINAL ARTICLE

Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain

S Kudo¹, Y Nomura², M Segawa², N Fujita³, M Nakao³, C Schanen⁴, M Tamura¹

¹ Hokkaido Institute of Public Health, Sapporo 060-0819, Japan
² Segawa Neurological Clinic for Children, Tokyo 101-0062, Japan
³ Institute of Molecular Embryology and Genetics, Kumamoto University School of Medicine, Kumamoto 860-0811, Japan
⁴ Nemours Research, Alfred I duPont Hospital for Children, Wilmington, DE19803, USA

Correspondence to:
Correspondence to:
Dr S Kudo, Hokkaido Institute of Public Health, Kita-19, Nishi-12, Kita-ku, Sapporo 060-0819, Japan;
kudos{at}iph.pref.hokkaido.jp

Rett syndrome is a neurodevelopmental disorder with severe mental retardation caused by mutations in the MECP2 gene. Mutations in the MECP2 gene are also associated with other genetic disorders, including X linked mental retardation in males. Missense mutations identified so far are present primarily in the methyl CpG binding domain (MBD) of MECP2. Here, the functional significance of 28 MBD missense mutations identified in patients were analysed by transient expression of the mutant proteins in cultured cells. The effects of mutations were evaluated by analysis of the affinity of MeCP2 to pericentromeric heterochromatin in mouse L929 cells and on transcriptional repressive activity of MeCP2 in Drosophila SL2 cells. These analyses showed that approximately one-third (9/28) of MBD missense mutations showed strong impairment of MeCP2 function. The mutation of the R111 residue, which directly interacts with the methyl group of methyl cytosine, completely abolished MeCP2 function and mutations affecting ß-sheets and a hairpin loop have substantial functional consequences. In contrast, mutations that showed marginal or mild impairment of the function fell in unstructured regions with no DNA interaction. Since each of these mutations is known to be pathogenic, the mutations may indicate residues that are important for specific functions of MeCP2 in neurones.

Keywords: MECP2 mutation; functional analysis; Rett syndrome; methylation

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Neul, J. L., Fang, P., Barrish, J., Lane, J., Caeg, E. B., Smith, E. O., Zoghbi, H., Percy, A., Glaze, D. G. (2008). Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome. Neurology 70: 1313-1321 [Abstract] [Full Text]  
• Kumar, A., Kamboj, S., Malone, B. M., Kudo, S., Twiss, J. L., Czymmek, K. J., LaSalle, J. M., Schanen, N. C. (2008). Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. J. Cell Sci. 121: 1128-1137 [Abstract] [Full Text]  
• Nan, X., Hou, J., Maclean, A., Nasir, J., Lafuente, M. J., Shu, X., Kriaucionis, S., Bird, A. (2007). Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc. Natl. Acad. Sci. USA 104: 2709-2714 [Abstract] [Full Text]  
• Petel-Galil, Y, Ben-Zeev, B, Greenbaum, I, Vecsler, M, Goldman, B, Lohi, H, Minassian, B A, Gak, E (2006). Comprehensive diagnosis of Rett's syndrome relying on genetic, epigenetic and expression evidence of deficiency of the methyl-CpG-binding protein 2 gene: study of a cohort of Israeli patients. J. Med. Genet. 43: e56-e56 [Abstract] [Full Text]  
• Nomura, Y., Segawa, M. (2005). Natural History of Rett Syndrome. J Child Neurol 20: 764-768 [Abstract]  
• Ham, A. L., Kumar, A., Deeter, R., Schanen, N. C. (2005). Does Genotype Predict Phenotype in Rett Syndrome?. J Child Neurol 20: 768-778 [Abstract]  
• Nomura, Y., Segawa, M. (2005). Natural History of Rett Syndrome. J Child Neurol 20: 764-768 [Abstract]  
• Ham, A. L., Kumar, A., Deeter, R., Schanen, N. C. (2005). Does Genotype Predict Phenotype in Rett Syndrome?. J Child Neurol 20: 768-778 [Abstract]  
• Neul, J. L., Zoghbi, H. Y. (2004). Rett Syndrome: A Prototypical Neurodevelopmental Disorder. Neuroscientist 10: 118-128 [Abstract]